Last edition
News about "AusperBio Therapeutics"
AusperBio Doses First Patient in HBV Candidate AHB-171 Study
AusperBio has dosed the first patient in the AHB-171 clinical study, advancing its HBV pipeline and proprietary Au-HALO liver-targeting delivery technology siRNA platform.
AusperBio Therapeutics | 03/08/2026 | By News Bureau
AusperBio Receives USD 37 Million in Series A Financing Round
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. has announced the completion of a USD 37 million Series A financing round.
AusperBio Therapeutics | 16/07/2024 | By Aishwarya | 646
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy